A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)
NCT ID: NCT06211764
Last Updated: 2025-11-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE3
272 participants
INTERVENTIONAL
2024-04-09
2031-04-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A: TAR-200
Participants will receive intravesical TAR-200 every 3 weeks during an induction phase and every 12 weeks during a maintenance phase.
TAR-200
Participants will receive TAR-200 intravesically.
Group B: Mitomycin C (MMC) or Gemcitabine
Participants will receive either single agent intravesical MMC or gemcitabine every week during an induction phase and every 4 weeks during a maintenance phase.
Mitomycin C
Participants will receive MMC intravesically.
Gemcitabine
Participants will receive gemcitabine intravesically.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TAR-200
Participants will receive TAR-200 intravesically.
Mitomycin C
Participants will receive MMC intravesically.
Gemcitabine
Participants will receive gemcitabine intravesically.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants with variant histologic subtypes are allowed if tumor(s) demonstrate urothelial (transitional cell histology) predominance. However, neuroendocrine, and small cell variants will be excluded
* Participants must be ineligible for or have elected not to undergo Radical Cystectomy (RC)
* Have an Eastern Cooperative Oncology Group (ECOG) performance status Grade of 0, 1, or 2
Exclusion Criteria
* Presence of any bladder or urethral anatomic feature that, in the opinion of the Investigator, may prevent the safe placement, indwelling use, or removal of TAR-200. Participants with tumors involving the prostatic urethra in men will be excluded
* A history of clinically significant polyuria with recorded 24-hour urine volumes greater than 4000 milliliters (\>4000 mL)
* Indwelling catheters are not permitted; however, intermittent catheterization is acceptable
* Previous treatment with TAR-200
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Janssen Research & Development, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Janssen Research & Development, LLC Clinical trial
Role: STUDY_DIRECTOR
Janssen Research & Development, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arkansas Urology
Little Rock, Arkansas, United States
Genesis Research LLC
Los Alamitos, California, United States
USC Norris Comprehensive Cancer Center
Los Angeles, California, United States
University of California Irvine Medical Center
Orange, California, United States
University of California San Francisco
San Francisco, California, United States
Genesis Research LLC
Torrance, California, United States
Colorado Clinical Research
Lakewood, Colorado, United States
Florida Urology Partners
Riverview, Florida, United States
Northwestern University
Chicago, Illinois, United States
UroPartners
Chicago Ridge, Illinois, United States
Urology of Indiana
Carmel, Indiana, United States
First Urology, PSC
Jeffersonville, Indiana, United States
Wichita Urology Group
Wichita, Kansas, United States
Comprehensive Urology
Royal Oak, Michigan, United States
Specialty Clinical Research of St Louis
St Louis, Missouri, United States
Associated Medical Professionals
Syracuse, New York, United States
The Urology Group
Cincinnati, Ohio, United States
Central Ohio Urology Group
Gahanna, Ohio, United States
Centers for Advanced Urology LLC d b a MidLantic Urology
Bala-Cynwyd, Pennsylvania, United States
Ralph H. Johnson Veterans Affairs Medical Center
Charleston, South Carolina, United States
Carolina Urologic Research Center
Myrtle Beach, South Carolina, United States
Low Country Urology Clinics
North Charleston, South Carolina, United States
Urology Associates
Nashville, Tennessee, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Urology Austin
Austin, Texas, United States
Urology Clinics of North Texas
Dallas, Texas, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Houston Metro Urology
Houston, Texas, United States
Spokane Urology
Spokane, Washington, United States
Clinica Santa Isabel
Buenos Aires, , Argentina
Investigaciones Clinico Moleculares (ICM)
CABA, , Argentina
Cemaic Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica
Córdoba, , Argentina
Centro Urologico Profesor Bengio
Córdoba, , Argentina
Hospital Privado de la Comunidad
Mar del Plata, , Argentina
AZ Sint-Jan
Bruges, , Belgium
Cliniques Universitaires Saint Luc
Brussels, , Belgium
Ziekenhuis Oost-Limburg
Genk, , Belgium
Algemeen ziekenhuis Maria Middelares
Ghent, , Belgium
Algemeen Ziekenhuis Delta
Roeselare, , Belgium
Fundacao Pio XII
Barretos, , Brazil
NAIC Nair Antunes Instituto do Cancer
Bauru, , Brazil
Hospital das Clinicas da Universidade Estadual de Campinas UNICAMP
Campinas, , Brazil
Liga Paranaense de Combate ao Cancer
Curitiba, , Brazil
Irmandade Santa Casa de Misericordia de Porto Alegre
Porto Alegre, , Brazil
Hospital da Bahia
Salvador, , Brazil
Sociedade Beneficente de Senhoras Hospital Sirio Libanes
São Paulo, , Brazil
Real e Benemérita Associação Portuguesa de Beneficência
São Paulo, , Brazil
Fundacao Antonio Prudente A C Camargo Cancer Center
São Paulo, , Brazil
Peking University First Hospital
Beijing, , China
West China School of Medicine/West China Hospital, Sichuan University
Cheng Du Shi, , China
Chongqing Cancer Hospital
Chongqing, , China
Sun Yat Sen University Cancer Center
Guangzhou, , China
Shengjing Hospital Of China Medical University
Shenyang, , China
Tianjin Medical University Cancer Institute and Hospital
Tianjin, , China
The Second Hospital Of Tianjin Medical University
Tianjin, , China
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, , China
Tongji Medical College of Huazhong University Science Technology of Medicine Health Management
Wuhan, , China
Xi an Jiaotong University Hospital
Xi'an, , China
Hopital Claude Huriez
Lille, , France
Polyclinique de Limoges - Francois Chenieux
Limoges, , France
Institut Paoli Calmettes
Marseille, , France
APHP - Hopital Bichat - Claude Bernard
Paris, , France
Clinique de la Croix du Sud
Quint-Fonsegrives, , France
Chu Rennes Hopital Pontchaillou
Rennes, , France
Hopital Foch
Suresnes, , France
Universitaetsklinikum Koeln
Cologne, , Germany
Universitaetsklinikum Halle Saale
Halle, , Germany
Klinikum Leverkusen gGmbH
Leverkusen, , Germany
Universitatsklinikum Schleswig Holstein Campus Lubeck
Lübeck, , Germany
Urologie Neandertal Praxis Mettmann
Mettmann, , Germany
Klinikum der Universitaet Muenchen
München, , Germany
Ospedale San Donato
Arezzo, , Italy
Ospedale Provinciale di Macerata
Macerata, , Italy
San Raffaele Hospital
Milan, , Italy
Istituto Dei Tumori Di Milano
Milan, , Italy
Ospedale S. Maria Delle Croci
Ravenna, , Italy
Universita Campus Bio-Medico di Roma
Roma, , Italy
Istituto Nazionale Tumori Regina Elena
Roma, , Italy
Istituto Clinico Humanitas
Rozzano, , Italy
PO Molinette Azienda Ospedaliero Universitaria Citta della Salute e della Scienza di Torino
Torino, , Italy
Funabashi Municipal Medical Center
Funabashi Shi, , Japan
Hakodate Goryoukaku Hospital
Hakodate, , Japan
Hyogo Prefectural Amagasaki General Medical Center
Hyōgo, , Japan
Niigata Cancer Center Hospital
Niigata, , Japan
National Hospital Organization Okayama Medical Center
Okayama, , Japan
Toho University Sakura Medical Center
Sakura, , Japan
Toranomon Hospital
Tokyo, , Japan
Yokohama City University Medical Center
Yokohama, , Japan
Uniwersytecki Szpital Kliniczny w Bialymstoku
Bialystok, , Poland
IN VIVO Sp. z o.o
Bydgoszcz, , Poland
Szpital Uniwersytecki w Krakowie
Krakow, , Poland
Uniwersytecki Szpital Kliniczny nr 4
Lublin, , Poland
Wojewodzki Szpital im Sw Ojca Pio w Przemyslu
Przemyśl, , Poland
Szpital Wojewodzki im Sw Lukasza SP ZOZ
Tarnów, , Poland
MICS Centrum Medyczne Torun
Torun, , Poland
Mazowiecki Szpital Onkologiczny
Wieliszew, , Poland
Dolnoslaskie Centrum Onkologii
Wroclaw, , Poland
Centrul Medical Unirea SRL
Brasov, , Romania
Ponderas Academic Hospital
Bucharest, , Romania
Institutul Oncologic Ion Chiricuta
Cluj-Napoca, , Romania
Regina Maria
Cluj-Napoca, , Romania
Spitalul Clinic Judetean de Urgenta Pius Brinzeu
Timișoara, , Romania
Chungbuk National University Hospital
Chungcheongbuk Do, , South Korea
Keimyung University Dongsan Hospital
Daegu, , South Korea
National Cancer Center
Gyeonggi-do, , South Korea
Chonnam National University Hwasun Hospital
Jeollanam-do, , South Korea
Seoul National University Hospital
Seoul, , South Korea
Samsung Medical Center
Seoul, , South Korea
The Catholic University of Korea Seoul St Mary s Hospital
Seoul, , South Korea
Pusan National University Yangsan Hospital
Yangsan, , South Korea
Hosp. Univ. Germans Trias I Pujol
Badalona, , Spain
Fund. Puigvert
Barcelona, , Spain
Hosp. Gral. Univ. Gregorio Maranon
Madrid, , Spain
Hosp. Univ. 12 de Octubre
Madrid, , Spain
Hosp Virgen de La Victoria
Málaga, , Spain
Hosp.Univ.Parc Tauli
Sabadell, , Spain
Hosp. Univ. Marques de Valdecilla
Santander, , Spain
Hosp. Virgen Del Rocio
Seville, , Spain
Hosp. Clinico Univ. de Valencia
Valencia, , Spain
St Bartholomews Hospital
London, , United Kingdom
Salford Royal Hospital
Salford, , United Kingdom
Southampton University Hospital
Southampton, , United Kingdom
Lister Hospital
Stevenage, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17000139BLC3004
Identifier Type: OTHER
Identifier Source: secondary_id
2023-507685-10-00
Identifier Type: REGISTRY
Identifier Source: secondary_id
17000139BLC3004
Identifier Type: -
Identifier Source: org_study_id